e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension
Souza Rogerio, Fernandes Caio J.C., Hoeper Marius M.
Source:
Eur Respir J 2014; 43: 963-965
Journal Issue:
April
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Souza Rogerio, Fernandes Caio J.C., Hoeper Marius M.. Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension. Eur Respir J 2014; 43: 963-965
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
The diagnostic value of exhaled carbon monoxide and arterial carboxyhaemoglobin measurements in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006
More on idiopathic pulmonary arterial hypertension with a low diffusing capacity
Source: Eur Respir J, 50 (2) 1700354; 10.1183/13993003.00354-2017
Year: 2017
Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD
Source: ERJ Open Res, 7 (1) 00706-2020; 10.1183/23120541.00706-2020
Year: 2021
Diffusing capacity of the lung for carbon monoxide (D
LCO
) and pulmonary blood flow during incremental and intermittent-work exercise tests
Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange
Year: 2008
Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2012; 39: 119-124
Year: 2012
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2011; 39: 119-124
Year: 2012
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
Source: Eur Respir J 2005; 26: 720-735
Year: 2005
Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Change in diffusing capacity for carbon monoxide as a predictor of outcomes in connective tissue disease-associated pulmonary arterial hypertension: Analysis from the REVEAL registry
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021
Pulmonary veno-occlusive disease
Source: Eur Respir J 2009; 33: 189-200
Year: 2009
Ventilatory inefficiency relative to oxygen uptake and carbon dioxide output are independent predictors of mortality in pulmonary arterial hypertension
Source: Annual Congress 2013 –Respiratory physiology in health and disease
Year: 2013
Does carbon monoxide diffusing capacity (DLCO) effect results of pulmonary rehabilitation?
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015
Adjusting diffusing capacity of the lung for carbon monoxide for haemoglobin level
Source: Eur Respir J 2013; 41: 489
Year: 2013
Carbon monoxide diffusing capacity (DLCO) usefulness in patients suffering from exertional dyspnea with or without oxygen desaturation during exercise testing
Source: Eur Respir J 2002; 20: Suppl. 38, 491s
Year: 2002
Exposition to CO among humans due to the measurement of the diffusing capacity by carbon monoxide
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007
Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis
Source: Eur Respir J, 50 (4) 1701008; 10.1183/13993003.01008-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept